Adenocarcinoma, Follicular - 50 Studies Found
Terminated |
: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer :
|
Completed |
: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer :
|
Not yet recruiting |
: Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery :
|
Active, not recruiting |
: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery :
|
Completed |
: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer :
|
Completed |
: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer :
|
Recruiting |
: Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers :
|
Active, not recruiting |
: Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer :
|
Completed |
: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu :
|
Completed |
: Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer : Head and Neck Cancer : 1999-12-10 :
|